Treatment Guidelines for Vaginal Candidiasis After Fluconazole Failure

Initial Assessment and Classification

The Infectious Diseases Society of America recommends that for vaginal candidiasis that has failed 2 doses of fluconazole 150 mg, fluconazole 150 mg should be administered every 72 hours for a total of 3 doses to treat severe/complicated disease 1
After fluconazole failure, the case meets criteria for complicated vulvovaginal candidiasis, which requires extended therapy rather than single-dose treatment, according to the Infectious Diseases Society of America 1, 2
Key factors to assess include severity of symptoms, species identification through culture, and predisposing factors such as diabetes, immunosuppression, and recent antibiotic use, as recommended by the Infectious Diseases Society of America 1

For Candida albicans, the primary approach is to complete the 3-dose fluconazole regimen, which achieves significantly higher clinical cure rates compared to single-dose therapy for severe disease, according to the Infectious Diseases Society of America 1, 2
If the 3-dose fluconazole regimen fails, alternative treatments include topical azole therapy for 7-14 days, as recommended by the Infectious Diseases Society of America 1, 2
For Candida glabrata, the first-line treatment is boric acid 600 mg intravaginal gelatin capsules daily for 14 days, as recommended by the Infectious Diseases Society of America 1
For Candida krusei, all topical azole agents remain effective despite fluconazole resistance, and any topical azole can be used for 7-14 days, according to the Infectious Diseases Society of America 1, 2

For recurrent vulvovaginal candidiasis, the induction phase consists of 10-14 days of topical therapy or oral fluconazole, followed by a maintenance phase of fluconazole 150 mg weekly for 6 months, as recommended by the Infectious Diseases Society of America 1, 2
This maintenance regimen achieves 90.8% disease-free rates at 6 months versus 35.9% with placebo, according to the Infectious Diseases Society of America 1, 2

Before proceeding with extended therapy, the diagnosis should be confirmed with wet mount and vaginal pH measurement, and if negative, vaginal cultures should be obtained for Candida species identification and susceptibility testing, as recommended by the Infectious Diseases Society of America 1